Literature DB >> 23895568

Direct and nitroxyl (HNO)-mediated reactions of acyloxy nitroso compounds with the thiol-containing proteins glyceraldehyde 3-phosphate dehydrogenase and alkyl hydroperoxide reductase subunit C.

Susan Mitroka1, Mai E Shoman, Jenna F DuMond, Landon Bellavia, Omar M Aly, Mohamed Abdel-Aziz, Daniel B Kim-Shapiro, S Bruce King.   

Abstract

Nitroxyl (HNO) reacts with thiols, and this reactivity requires the use of donors with 1-nitrosocyclohexyl acetate, pivalate, and trifluoroacetate, forming a new group. These acyloxy nitroso compounds inhibit glyceraldehyde 3-phosphate dehydrogenase (GAPDH) by forming a reduction reversible active site disulfide and a reduction irreversible sulfinic acid or sulfinamide modification at Cys244. Addition of these acyloxy nitroso compounds to AhpC C165S yields a sulfinic acid and sulfinamide modification. A potential mechanism for these transformations includes nucleophilic addition of the protein thiol to a nitroso compound to yield an N-hydroxysulfenamide, which reacts with thiol to give disulfide or rearranges to sulfinamides. Known HNO donors produce the unsubstituted protein sulfinamide as the major product, while the acetate and pivalate give substituted sulfinamides that hydrolyze to sulfinic acids. These results suggest that nitroso compounds form a general class of thiol-modifying compounds, allowing their further exploration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23895568      PMCID: PMC3798158          DOI: 10.1021/jm400057r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  59 in total

1.  Reaction of nitroxyl, an aldehyde dehydrogenase inhibitor, with N-acetyl-L-cysteine.

Authors:  D W Shoeman; F N Shirota; E G DeMaster; H T Nagasawa
Journal:  Alcohol       Date:  2000-01       Impact factor: 2.405

2.  Nitroxyl gets to the heart of the matter.

Authors:  Martin Feelisch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

3.  Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling.

Authors:  Nazareno Paolocci; Tatsuo Katori; Hunter C Champion; Marcus E St John; Katrina M Miranda; Jon M Fukuto; David A Wink; David A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

4.  Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects.

Authors:  C M Maragos; D Morley; D A Wink; T M Dunams; J E Saavedra; A Hoffman; A A Bove; L Isaac; J A Hrabie; L K Keefer
Journal:  J Med Chem       Date:  1991-11       Impact factor: 7.446

5.  Nitric oxide activates skeletal and cardiac ryanodine receptors.

Authors:  D Stoyanovsky; T Murphy; P R Anno; Y M Kim; G Salama
Journal:  Cell Calcium       Date:  1997-01       Impact factor: 6.817

6.  A tetrahydrobiopterin radical forms and then becomes reduced during Nomega-hydroxyarginine oxidation by nitric-oxide synthase.

Authors:  Chin-Chuan Wei; Zhi-Qiang Wang; Craig Hemann; Russ Hille; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2003-09-22       Impact factor: 5.157

7.  Oxidation of N-hydroxy-l-arginine by hypochlorous acid to form nitroxyl (HNO).

Authors:  Meredith R Cline; Tyler A Chavez; John P Toscano
Journal:  J Inorg Biochem       Date:  2012-10-05       Impact factor: 4.155

8.  NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation.

Authors:  D R Arnelle; J S Stamler
Journal:  Arch Biochem Biophys       Date:  1995-04-20       Impact factor: 4.013

9.  Nitroxyl analogs as inhibitors of aldehyde dehydrogenase. C-nitroso compounds.

Authors:  H T Nagasawa; Y Yost; J A Elberling; F N Shirota; E G DeMaster
Journal:  Biochem Pharmacol       Date:  1993-05-25       Impact factor: 5.858

10.  Prodrugs of nitroxyl as potential aldehyde dehydrogenase inhibitors vis-a-vis vascular smooth muscle relaxants.

Authors:  H T Nagasawa; S P Kawle; J A Elberling; E G DeMaster; J M Fukuto
Journal:  J Med Chem       Date:  1995-05-26       Impact factor: 7.446

View more
  7 in total

Review 1.  Recent advances in the chemical biology of nitroxyl (HNO) detection and generation.

Authors:  Zhengrui Miao; S Bruce King
Journal:  Nitric Oxide       Date:  2016-04-20       Impact factor: 4.427

2.  New acyloxy nitroso compounds with improved water solubility and nitroxyl (HNO) release kinetics and inhibitors of platelet aggregation.

Authors:  Heba A H Mohamed; Mohamed Abdel-Aziz; Gamal El-Din A A Abuo-Rahma; S Bruce King
Journal:  Bioorg Med Chem       Date:  2015-04-16       Impact factor: 3.641

3.  Ring expansions of acyloxy nitroso compounds.

Authors:  Mallinath B Hadimani; Rajeswari Mukherjee; Ranjan Banerjee; Mai E Shoman; Omar M Aly; S Bruce King
Journal:  Tetrahedron Lett       Date:  2015-10-21       Impact factor: 2.415

4.  Chemical proteomics reveals new targets of cysteine sulfinic acid reductase.

Authors:  Salma Akter; Ling Fu; Youngeun Jung; Mauro Lo Conte; J Reed Lawson; W Todd Lowther; Rui Sun; Keke Liu; Jing Yang; Kate S Carroll
Journal:  Nat Chem Biol       Date:  2018-09-03       Impact factor: 15.040

5.  HNO to NO Conversion Mechanism with Copper Zinc Superoxide Dismutase, Comparison with Heme Protein Mediated Conversions, and the Origin of Questionable Reversibility.

Authors:  Yelu Shi; Matthew A Michael; Yong Zhang
Journal:  Chemistry       Date:  2021-02-16       Impact factor: 5.236

Review 6.  Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties.

Authors:  Mai E Shoman; Omar M Aly
Journal:  Oxid Med Cell Longev       Date:  2015-12-07       Impact factor: 6.543

7.  Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1α Inhibition for Cancer Therapy.

Authors:  Eduardo Henrique Silva Sousa; Lisa A Ridnour; Florêncio S Gouveia; Carlos Daniel Silva da Silva; David A Wink; Luiz Gonzaga de França Lopes; Peter J Sadler
Journal:  ACS Chem Biol       Date:  2016-05-31       Impact factor: 5.100

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.